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Abstract
Background: Obesity is a health hazard that is associated with a number of diseases and metabolic abnormalities,
such as type-2 diabetes, hypertension, dyslipidemia, and coronary heart disease. In the current study, we
investigated the effects of Citrus aurantium flavonoids (CAF) on the inhibition of adipogenesis and adipocyte
differentiation in 3T3-L1 cells.
Methods: During adipocyte differentiation, 3T3-L1 cells were treated with 0, 10, and 50 μg/ml CAF, and then the
mRNA and protein expression of adipogenesis-related genes was assayed. We examined the effect of CAF on level
of phosphorylated Akt in 3T3-L1 cells treated with CAF at various concentrations during adipocyte differentiation.
Results: The insulin-induced expression of C/EBPb and PPARg mRNA and protein were significantly down-
regulated in a dose-dependent manner following CAF treatment. CAF also dramatically decreased the expression
of C/EBPa, which is essential for the acquisition of insulin sensitivity by adipocytes. Moreover, the expression of the
aP2 and FAS genes, which are involved in lipid metabolism, decreased dramatically upon treatment with CAF.
Interestingly, CAF diminished the insulin-stimulated serine phosphorylation of Akt (Ser473) and GSK3b (Ser9), which
may reduce glucose uptake in response to insulin and lipid accumulation. Furthermore, CAF not only inhibited
triglyceride accumulation during adipogenesis but also contributed to the lipolysis of adipocytes.
Conclusions: In the present study, we demonstrate that CAF suppressed adipogenesis in 3T3-L1 adipocytes. Our
results indicated that CAF down-regulates the expression of C/EBPb and subsequently inhibits the activation of
PPARg and C/EBPa. The anti-adipogenic activity of CAF was mediated by the inhibition of Akt activation and
GSK3b phosphorylation, which induced the down-regulation of lipid accumulation and lipid metabolizing genes,
ultimately inhibiting adipocyte differentiation.
Background
Obesity is a worldwide epidemic, and there are multiple
obesity-associated health problems, which include type-2
diabetes, hypertension, and cardiovascular disease [1].
Obesity is caused by an increase in adipose tissue mass,
which results from the multiplication of fat cells through
adipogenesis and the increased deposition of cytoplas-
mic triglycerides [2]. Adipocytes are highly specialized
cells that play a critical role in regulating lipid metabo-
lism and energy balance, and they are associated with
adipose tissue mass [3]. However, excess adipose tissue
leads to obesity and its associated diseases, which causes
serious health problems.
Adipogenesis is the process by which an undifferen-
tiated preadipocyte is converted to a fully differentiated
adipocyte [3]. Lipid accumulation increases throughout
the adipogenic process, and it is regulated by genetic
and growth factors [4]. The programmed differentiation
of preadipocytes is accompanied by an increase in the
expression of various transcription factors and adipo-
cyte-specific genes. 3T3-L1 cells develop from spindle-
shaped fibroblast cells into larger, spherical cells, accu-
mulate large triglyceride droplets, and activate adipo-
genic marker genes. The 3T3-L1 cell line is one of the
most reliable models for the study of the conversion of
preadipocytes into adipocytes [5]. During differentiation,
the action of adipogenic genes, which include C/EBPs
* Correspondence: jaehcho@gsnu.ac.kr
† Contributed equally
1Institute of Life Science, College of Veterinary Medicine, Gyeongsang
National University, Jinju, South Korea
Full list of author information is available at the end of the article
Kim et al. BMC Complementary and Alternative Medicine 2012, 12:31
http://www.biomedcentral.com/1472-6882/12/31
© 2012 Kim et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.and PPARg, induces adipogenesis [6,7]. Members of the
CCAAT-enhancer binding protein family (C/EBP-a,- b
and -δ) play important roles in adipogenesis [7]. C/EBPb
is expressed early in the adipocyte differentiation pro-
gram, and it initiates mitotic clonal expansion (MCE)
[8]. In response to an adipogenic induction, C/EBPb and
-δ are first activated to promote PPARg and C/EBPa
expression [7]. The transcription factor PPARg is a mas-
ter regulator of adipocyte differentiation, and its activa-
tion is both necessary and sufficient for adipocyte
differentiation [6]. The activation of C/EBPa and PPARg
leads to terminal differentiation through their subse-
quent transactivation of adipocyte-specific genes such as
fatty acid binding protein 4 (aP2), lipoprotein lipase
(LPL), and fatty acid synthase (FAS) [6,9].
The serine/threonine kinase Akt plays an essential role
in adipocyte differentiation. Mouse embryonic fibro-
blasts (MEFs) lacking Akt failed to differentiate into
mature adipocytes [10], and an RNAi-mediated
decreased in Akt was found to block the differentiation
of 3T3-L1 cells [11]. Moreover, the overexpression of
constitutively active Akt in 3T3-L1 adipocytes was
found to promote glucose uptake and adipocyte differ-
entiation [12]. Akt phosphorylates and regulates a large
number of substrates that are involved in a diverse array
of biological processes [13], many of which could contri-
bute to the role of Akt in driving adipocyte differentia-
tion. GSK3b is a critical downstream signaling protein
in the phosphoinositide 3-kinase (PI3K)/Akt pathway.
Insulin signaling activates Akt through PI3K and
induces the serine/threonine phosphorylation of down-
stream targets, such as GSK3b [14]. GSK3b is a critically
important protein kinase in adipocyte differentiation
because it phosphorylates a number of substrates,
including the transcription factor beta-catenin, CCAAT-
enhancer binding protein beta (C/EBPb), and C/EBPa,
and promotes glycogen synthesis (GS), which regulates
their function [15,16].
Citrus aurantium L. (CAL) produces many com-
pounds, such as flavonoids, limonoids, and polyphenols
[17,18]. The major flavonoids isolated from CAL include
hesperidin, naringenin, and nobiletin, and naringenin
and hesperetin have been used to treat cardiovascular
diseases [18,19]. Additionally, other studies have shown
that CAL extracts exhibit lipolytic activity in human adi-
pocytes [20], and Citrus aurantium-induced lipolytic
activity has been reported to reduce body fat mass in
obese humans [21]. However, the effects of Citrus aur-
antium on adipogenesis are not fully understood.
In the present study, the effect of CAF on adipocyte
differentiation in 3T3-L1 cells was investigated by mea-
suring lipid accumulation and evaluating the expression
levels of adipocyte marker genes and their target genes.
Moreover, we examined whether Akt and GSK3b
activation is critical for the anti-adipogenic functions of
CAF to better understand the specific mechanisms med-
iating CAF function. Our results show that the CAF
treatment of 3T3-L1 adipocytes inhibits the insulin-
induced phosphorylation of Akt at Ser473 and of
GSK3b at Ser9 and reduces insulin-stimulated PPARg,
C/EBPb,a n dC / E B P a expression, thus suppressing adi-
pocyte differentiation.
Methods
Cell culture
Cell culture media and supplements were obtained from
Sigma-Aldrich (St. Louis, MO, USA). Mouse 3T3-L1
preadipocytes were grown in Dulbecco’s modified eagle
medium (DMEM) high glucose containing 10% calf
serum at 37°C in a humidified atmosphere of 5% CO2.
The cells were subcultured after reaching 80% conflu-
ence. To induce adipogenesis, 3T3-L1 cells were cul-
tured until confluent, and 1 day after reaching
confluence (day 0), the culture medium was exchanged
with a differentiation/induction medium (DMII) con-
taining 100 mM insulin, 0.5 mM 3-isobutyl-1-methyl-
xanthine, 100 μM indomethasone, 0.25 μM
dexamethasone and 10% fetal bovine serum in DMEM.
The DMII was changed every 2 days. The 3-isobutyl-1-
methylxanthine, dexamethasone, indomethasone, and
Oil-red O were purchased from Sigma-Aldrich (St.
Louis, MO, USA). CAF was added to the culture med-
ium containing adipocytes at day 0. Cells were treated
with 0, 10, or 50 μg/ml of CAF. After treatment with
CAF for 4 or 6 days, the 3T3-L1 adipocytes were lysed
for experimental analysis. CAF cytotoxicity was evalu-
ated by 3-(4,5-demethylthiazol-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT) assay for cell viability.
Preparation of Citrus aurantium Flavonoids
The CAF extracts were supplied by Dr. Shin (Depart-
ment of Chemistry, Gyeongsang National University)
and Kim (Department of Biochemistry, Gyeongsang
National University). CAL consists of many flavonoids,
naringin, hesperidin, poncirin, isosiennsetin, hexam-
ethoxyflavone, sineesytin, hexamethoxyflavone, tet-
ramrthnl-o-isoscutellaeein, nobiletin,
heptamethoxyflavone, 3-hydoxynobiletin, tangeretin,
hydroxypentamethoxyflavone, and hexamethoxyflavone
[22,23].
Oil-red O staining
Cells were treated either with CAF (10 μg/ml or 50 μg/
ml) or vehicle in differentiation medium from days 0-6
of adipogenesis. On day 4 or 6, cells were stained with
Oil-red O. For Oil-red O staining, cells were washed
gently with phosphate-buffered saline (PBS) and stained
with filtered Oil-red O solution (in 60% isopropanol and
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the Oil-red O staining solution was removed, and the
plates were rinsed with water and dried. The stained
lipid droplets were viewed on an Olympus microscope
(Tokyo, Japan).
Measurement of triglyceride content
Cellular triglyceride contents were measured using a
commercially available triglyceride assay kit (Sigma-
Aldrich, St. Louis, MO, USA) according to the manufac-
turer’s instructions. Adipocytes differentiated for 4 or 6
days were treated with CAF at concentrations of 0, 10,
and 50 μg/ml in 6-well plates. To analyze the cellular
triglyceride content, cells were washed with PBS and
then scraped into 200 μl PBS and homogenized by soni-
cation for 1 min. The total triglycerides in the lysates
were measured using the assay kits.
RT-PCR
Total RNA was isolated from 3T3-L1 adipocytes using
Trizol reagent (Invitrogen, CA, USA). A 1 μg sample of
total RNA was subjected to first-strand cDNA synthesis
with oligo (deoxythymidine) primers and Superscript II
reverse transcriptase (Invitrogen, CA, USA). The target
cDNA was amplified using the following sense and anti-
sense primers: sense 5’-GACTACGCAACACACGTG-
TAACT-3’ and antisense 5’-CAAAACCAAAAAC
ATCAACAACCC-3’ for C/EBPb;s e n s e5 ’-TTT-TCA-
AGG-GTG-CCA-GTT-TC-3’ and antisense 5’-AAT-
CCT-TGG-CCC-TCT-GAG-AT-3’ for PPARg; sense 5’-
TCC-AAG-GAA-GCC-TTT-GAG-AA-3’ and antisense
5’-CCA-TCC-TCA-GTC-CCA-GAA-AA-3’ for LPL; b-
actin was detected as a control using sense (5’-
GACAACGGCTCCGGCATGTGCAAAG-3’)a n da n t i -
sense (5’-TTCACGGTTGGCCTTAGGGTTCAG-3’) pri-
mers under the same conditions.
Western blot analysis
Western blotting was performed according to standard
procedures [11]. Briefly, cells were lysed in a buffer con-
taining 50 mM Tris-HCl (pH 8.0), 0.4% Nonidet P-40,
120 mM NaCl, 1.5 mM MgCl2,0 . 1 %S D S ,2m Mp h e n y l -
methylsulfonyl fluoride, 80 μg/ml leupeptin, 3 mM NaF
and 1 mM DTT. Cell lysates were separated by 10% SDS-
polyacrylamide gel electrophoresis, transferred onto a
polyvinylidene fluoride membrane (Amersham Pharma-
cia, England, UK), blocked with 5% skim milk and hybri-
dized with primary antibodies. PPARg,C / E B P b,C / E B P a,
aP2, Akt, FAS and GSK3b antibodies were from Cell Sig-
naling and the monoclonal b-actin antibody was from
Chemicon. HRP-labeled mouse anti-rabbit IgG was
obtained from Jackson ImmunoResearch. After incuba-
tion with horseradish-peroxidase-conjugated secondary
antibody at room temperature, immunoreactive proteins
were detected using a chemiluminescent ECL assay kit
(Amersham Pharmacia, UK) according to the manufac-
turer’s instructions.
Lipolysis assay
To obtain fully differentiated 3T3-L1 adipocytes, conflu-
ent cells were induced to differentiate in DMII medium
for 6 days. The differentiated 3T3-L1 adipocytes were
then incubated with 0, 10, or 50 μg/ml of CAFs for 24
hours. The conditioned media was then removed from
each well and assayed for glycerol content with free gly-
cerol determination kit (Sigma-Aldrich, St. Louis, MO,
USA).
Statistical analysis
Data are expressed as the means ± SD. Comparison
between groups made by ANOVA variance analysis, and
significance was analyzed by Duncan’s multiple range
tests. Differences of p < 0.05 were considered to be sta-
tistically significant.
Results
Citrus aurantium flavonoids (CAF) inhibits 3T3-L1
adipocyte differentiation
To examine the effect of CAF on adipocyte differentia-
tion, 3T3-L1 preadipocytes were treated with various
concentrations (0, 10, or 50 μg/ml) of CAF in the pre-
sence of DMII (0.5 mM 3-isobutyl-1-methylxanthine,
100 μM indomethacin, 0.25 μM dexamethasone and 100
mM insulin) or DMII alone. The differentiation medium
was exchanged with medium containing the DMII mix-
ture every two days. The medium that contained CAF
accumulated lipid droplets from day 0 to day 6, and the
droplets were visualized by Oil-red O staining on day 6.
On day 6 post-induction, oil droplets were not visible in
the medium of undifferentiated 3T3-L1 cells, but many
lipid droplets were visible in that of the fully differen-
tiated cells treated with DMII. The presence of lipid
droplets was used as a marker of lipid accumulation.
Figure 1 shows that CAF displays anti-adipogenic prop-
erties, which is indicated by the decreased levels of Oil-
red O staining at differentiation day 6 (Figure 1A).
Microscopic observations of the Oil-red O staining
revealed a reduction in the amount of lipid droplets
with increasing concentrations of CAF in a dose-depen-
dent manner (Figure 1B). The highest CAF concentra-
tion used (50 μg/ml) strongly inhibited the
differentiation of 3T3-L1 preadipocytes into adipocytes
and prevented lipid accumulation. The inhibitory effects
of CAF on triglyceride accumulation during adipogen-
esis were also dose-dependent. The MTT assay was
used to determine the effect of CAF on the proliferation
of 3T3-L1 preadipocytes. Treatment with CAF had no
significant inhibitory effects on cell viability in cells
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induction (Figure 1C). These results demonstrate that
CAF strongly blocks adipocyte differentiation in 3T3-L1
cells without affecting viability or proliferation.
The effect of CAF on the expression of adipocyte-specific
genes during adipocyte differentiation
To investigate the effects of CAF on the differentiation of
3T3-L1 preadipocytes, 3T3-L1 cells were differentiated in
Figure 1 Effect of CAF on lipid accumulation of 3T3-L1 adipocytes. Confluent 3T3-L1 preadipocytes differentiated into adipocytes in
medium containing different concentrations of CAF for 6 days (from day 0 to 6). Con, 3T3-L1 preadipocytes; DMII, fully differentiated adipocytes;
10 μg/ml, fully differentiated adipocytes (DMII + 10 μg/ml CAF); 50 μg/ml, fully differentiated adipocytes (DMII + 50 μg/ml CAF). (A, B) Inhibitory
effects of CAF on lipid accumulation in 3T3-L1 adipocytes. The intracellular lipid accumulation quantified by Oil-red O staining and also optically
observed by an inverted microscope. Oil-red O staining assay for lipid droplets was performed on day 6 after induction of differentiation. (C)
Effect of CAF on cell viability in preadipocyte and differentiated adipocytes. These data were presented as relative cell viability values. Data are
mean ± SD values of at least three independent experiments. Each experiment was performed in triplicate.
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days. Adipogenesis is accompanied by the increased
expression of various transcription factors and adipocyte-
specific genes. PPARg and C/EBPb are two key transcrip-
tion factors that are involved in adipogenesis. RT-PCR ana-
lysis revealed that the expression of C/EBPb and PPARg
mRNA was highly induced at day 4 or 6 of adipogenesis,
whereas the expression of those genes was significantly
decreased in cells treated with CAF (Figure 2A and 2B).
However, LPL mRNA expression was not changed signifi-
cantly by CAF treatment (Figure 2A and 2B). Western blot
analysis was conducted to further examine the effect of
CAF on the regulation of adipogenic markers at the protein
level. As expected, the expression of adipogenic markers,
which included PPARg,C / E B P a, and C/EBPb, was signifi-
cantly up-regulated during differentiation (Figure 2C and
2D). However, the expression of PPARg, C/EBPa, and C/
EBPb was significantly decreased in a time- and dose-
dependent manner by the continuous CAF treatment in
3T3-L1 cells, although the expression of C/EBPa and C/
EBPb was only slightly decreased in the cells treated with
10 μg/ml CAF (Figure 2C and 2D). We further investigated
whether the CAF-induced reduction of PPARg and C/
EBPa regulated the expression of their target genes, such
as FAS and aP2. Treatment of 3T3-L1 adipocytes with
CAF significantly down-regulated the expression of aP2
and FAS genes in a dose-dependent manner compared to
treatment with DMII without CAF (Figure 2C and 2D).
The effect of CAF on the regulation of Akt and GSK3b
during adipocyte differentiation
To determine whether CAF changed the phosphorylation
levels of molecules that were downstream of insulin signal-
ing, 3T3-L1 adipocytes were treated with DMII alone or
with DMII and CAF. Lysates were collected and immuno-
blotted with total Akt, total GSK3b, phospho-Akt (Ser473),
and phospho-GSK3b (Ser9) antibodies. In the DMII and
DMII + CAF samples, wild type Akt and GSK3b were
expressed at similar levels. DMII stimulation of 3T3-L1 adi-
pocytes resulted in a significant increase in phospho-Akt
and phospho-GSK3b (Figure 3A and 3B). In the presence of
CAF, the expression of phospho-Akt was dramatically
decreased in 3T3-L1 adipocytes (Figure 3A). Similar to
these findings, the expression of phospho-GSK3b during
3T3-L1 differentiation was also dramatically decreased by
CAF treatment (Figure 3B). These results demonstrate that
CAF treatment inhibits the phosphorylation of Akt, which
suppresses the phosphorylation of its substrate kinase
GSK3b.
CAF inhibits lipid accumulation and induces lipolysis in
3T3-L1 adipocytes
To explore the effect of CAF on the inhibition of intra-
cellular triglyceride accumulation, 3T3-L1 preadipocytes
were differentiated with CAF for 6 days. Lipid accumu-
l a t i o n ,w h i c hw a su s e da samajor marker of adipogen-
esis, was quantified on day 4 and day 6 of the
differentiation period. The results show that treatment
of CAF reduces triglyceride content and that the inhibi-
tion of intracellular triglyceride accumulation in 3T3-L1
adipocytes occurs in a dose-dependent manner (Figure
4A). We then investigated whether the reduction in tri-
glyceride content was associated with lipolysis. 3T3-L1
adipocytes were treated with CAF concentrations of 0,
10, and 50 μg/ml. The lipolytic activity of CAF was
determined by measuring the glycerol levels that were
released in the medium. Fully differentiated 3T3-L1 adi-
pocytes were treated with DMII every two days over the
course of 6 days, and the cells were then treated with
medium containing CAF for 24 hours. The small
amount of glycerol released into the media was observed
in 3T3-L1 adipocytes treated with DMII. However, CAF
treatment increased glycerol secretion in a dose-depen-
dent manner, which indicated that CAF strongly stimu-
lated lipolysis in differentiated 3T3-L1 adipocytes
(Figure 4B).
Discussion
In the present study, we examined the anti-obesity effect
of CAF in 3T3-L1 cells by measuring lipid accumulation
and by analyzing changes in adipocyte differentiation,
which modulates adipocyte-specific gene expression and
Akt phosphorylation. We demonstrated that CAF treat-
ment inhibited lipid accumulation and the differentia-
tion of 3T3-L1 preadipocytes into adipocytes in a dose-
dependent manner. CAF treatment decreased the
expression of key adipocyte differentiation regulators,
including C/EBPb, C/EBPa and PPARg, and down-regu-
lated Akt phosphorylation. These results suggest that
CAF plays a critical role in preventing adipogenesis and
the accumulation of cytoplasmic lipid droplets during
the differentiation in 3T3-L1 cells.
Adipocyte differentiation and fat accumulation are
associated with the occurrence and development of obe-
sity [24]. Hyperplastic obesity is caused by an increase
in the number of fat cells relative to the increase in adi-
pose tissue mass. A reduction of adiposity is related to
the inhibition of angiogenesis along with a reduction of
adipocyte numbers and the lipid content of adipocytes.
The differentiation of preadipocytes into adipocytes is
regulated by a complex network of transcription factors.
At the center of this network are nuclear receptor
PPARg and members of C/EBP family, which initiate the
entire adipogenic program and regulate the process of
terminal differentiation [7]. The expression of C/EPBa
and PPARg cross-regulate each other through a positive
feedback loop and transactivate downstream target
genes, such as aP2, LPL, and FAS, that are adipocyte
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phenotype [6,9]. In the present study, CAF treatment
remarkably reduced the level of Oil-red O staining in a
dose-dependent manner, and microscopic inspection
revealed a significant decrease in the level of accumu-
lated intracellular triglyceride. The triglyceride levels of
cells treated with 50 μg/ml CAF displayed a marked
reduction in adipogenesis. These results indicate that
Figure 2 Effect of CAF on the expression of adipogenesis-related genes in 3T3-L1 adipocytes. 3T3-L1 cells were differentiated in the
absence or presence of CAF for 4 or 6 days. (A) CAF inhibited the expression of adipocyte-specific transcription factors, C/EBPb and PPARg
mRNA during adipocyte differentiation. The differentiation of 3T3-L1 preadipocytes was induced by DMII medium in the absence or presence of
10 and 50 μg/ml CAF. Total RNA was isolated from 3T3-L1 adipocytes at day 4 and day 6 after induction of differentiation. The expression of C/
EBPb and PPARg was examined by RT-PCR. (B) The relative expression of adipocyte-specific genes after treating CAF for 4 or 6 days. All gene
expressions were normalized using b-actin as a reference gene. The data shown are representative of three independent experiments. (*) p <
0.05, (**) P < 0.01 versus the control (DMII) group at each gene expression. (C) CAF inhibited the expression of adipogenesis-related genes in
3T3-L1 adipocytes. Total cell lysates were isolated from 3T3-L1 adipocytes at day 4 and day 6 after induction of differentiation. Immunoblotting
analysis was performed as described in Materials and Methods. (D) The relative expression of adipogenesis-related genes after treating CAF for 4
or 6 days. The data shown are representative of three independent experiments. (*) p < 0.05, (**) P < 0.01, (***) P < 0.001 versus the control
(DMII) group at each gene expression.
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cytes into adipocytes and also inhibited the accumula-
tion of lipid droplets in the cytoplasm, an adipocyte
phenotype that follows differentiation based on lipid
accumulation. Our results show that CAF treatment sig-
nificantly down-regulated PPARg and C/EBPb at the
mRNA and protein levels, compared to those in fully
differentiated adipocytes. PPARg and C/EBPb, which are
Figure 3 Effect of CAF on phosophorylation of Akt and GSK3b during 3T3-L1 differentiation. 3T3-L1 preadipocytes were differentiated in
the absence or in the presence of CAF for 6 days. (A) Immunoblotting analysis for wild type Akt and pAkt (Ser 473) was described under
Materials and Methods. These experiments were conducted as independent experiments in triplicate. Data represent the mean ± SD. (*) p <
0.05. (B) Immunoblotting analysis for wild type GSK3b and pGSK3b (Ser-9) was described under Materials and Methods. These experiments were
performed as independent experiments in triplicate. Data represent the mean ± SD. (*) p < 0.05.
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to the transcriptional activation of most adipocyte-speci-
fic genes [7]. Moreover, PPARg-deficient cells fail to dif-
ferentiate into adipocytes, and the overexpression of
PPARg and C/EBPa accelerates adipogenesis [25].
Therefore, these results suggest that CAF suppresses
adipocyte differentiation through PPARg and C/EBPb in
the early stages of adipocyte differentiation.
We focused on the effects of CAF on the regulation of
aP2 and FAS expression during 3T3-L1 differentiation.
PPARg and C/EBPa synergistically activate the down-
stream promoters of adipocyte-specific genes such as
aP2 and FAS. The aP2 gene is a terminal differentiation
maker of adipocytes, and it facilitates the cellular uptake
of long-chain fatty acids in a pathway linking fatty acid
metabolism and obesity [26]. FAS is a lipogenic enzyme
that facilitates the synthesis and cytoplasmic storage of
massive amounts of triglycerides [27]. In the current
study, the presence of CAF suppressed the expression of
aP2 and FAS, which suggested that CAF inhibits adipo-
genesis through the down-regulation of C/EBPa and
PPARg. Furthermore, the down-regulation of aP2 and
FAS decreased fatty acid utilization and fatty acid trans-
port in 3T3-L1 adipocytes. However, we did not observe
any change in the expression of LPL, which is also con-
trolled by PPARg and C/EBPa.C o n s i s t e n tw i t ho u r
results, hydroxytyrosol from olive oil inhibited lipid
accumulation during adipocyte differentiation and inhib-
ited the expression of all genes tested, except LPL [28].
CAF stimulated lipolysis, which induced glycerol release
when added to mature adipocytes, correlated to the
CAF-induced down-regulation of adipogenic gene
expression. Therefore, these results strongly suggest that
CAF prevents adipogenesis through the inhibition of
PPARg and C/EBPa gene expression, reduces the
expression of adipogenesis- and lipid metabolism-
Figure 4 Effect of CAF on triglyceride accumulation and lypolytic activity in 3T3-L1 adipocytes. Confluent 3T3-L1 preadipocytes were
differentiated into adipocytes in DMII medium for 6 days. (A) CAF reduced TG content during differentiation of 3T3-L1 cells. 3T3-L1
preadipocytes were differentiated in the absence or presence of CAF for 4 or 6 days, and the lipid accumulation was measured by triglyceride
assay. Data are mean ± SD values of at least three independent experiments. (*) p < 0.05, (**) P < 0.01 compared with the differentiated
adipocytes (control). (B) CAF increased lipolytic activity in 3T3-L1 adipocytes. The lypolytic activity of CAF was determined by measuring glycerol
levels secreted in medium. All experiments were performed on triplicates for each treatment. Values represent mean ± SD. (*) p < 0.05, (**) P <
0.01 compared with the untreated adipocytes (control).
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L1 adipocytes.
Citrus fruits are abundant sources of compounds that
help prevent lifestyle-related diseases such as diabetes,
high blood pressure, and cancer. CAL contains many
flavonoid components, such as naringin, hesperidin,
poncirin, isosinnesetin, hexamethoxyflavone, sinestin,
nobletin, heptamethoxyflavone, tangeretins, and hydro-
xypentamethoxyflavone [22,23]. Polymethoxylated fla-
vones from citrus improve lipid and glucose
homeostasis and increase adiponectin in fructose-
induced insulin-resistant models [29]. Citrus depressa
Hayata extracts show antiobesity effects in high-fat diet-
induced obese mice [30]. Other studies have reported
that dietary flavonoids, which include catechin, querce-
tin, kaempferol, and genistein, inhibit adipogenesis in
3T3-L1 adipocytes [29,31]. Mercader et al. showed that
a Citrus aurantium extract exhibited lipolytic activity in
human adipocytes, providing the basis for an anti-obe-
sity effect [20].
Many studies using natural substances and herbal
compounds focus on the activity of the PI3K/Akt signal-
ing pathway in preventing obesity; hormones and
growth factors that are specific to adipogenesis act via
their receptors to transduce external differentiation sig-
nals through a cascade of intracellular events in the
PI3K/Akt signaling pathway [32]. Thus, Akt activation
has been identified as a major target for the control of
obesity and diabetes [12]. Akt plays a critical role in the
insulin signaling pathway, and the insulin-stimulated
phosphorylation of Akt via PI3K is an important indica-
tor of proper insulin function [13]. Constitutively active
Akt causes the spontaneous differentiation of 3T3-L1
cells in the absence of insulin stimulation [12]. The Akt
signal cascade is important for adipogenesis, and it acti-
vates PPARg and C/EBPa during 3T3-L1 adipocyte dif-
ferentiation [11]. Moreover, Akt regulates adipogenesis
via the phosphorylation and inactivation of substrates
such as Foxo1 and GSK3b, which directly regulate
PPARg,C / E B P b,C / E B P a, and GS [15,16]. Therefore, to
investigate the molecular mechanism underlying the
anti-adipogenesis stimulated by CAF, we studied the
effects of CAF on the activation of Akt. Our results
demonstrate that CAF caused a marked and dose-
dependent attenuation of the Akt phosphorylation
(Ser473) induced by insulin. However, DMII induction
of the 3T3-L1 cells increased Akt activation, which is
consistent with enhanced Akt phosphorylation. Our
results strongly support the conclusions of a previous
study showing that naringenin, which is derived from
Citrus aurantium, inhibits phosphotidylinositide-3-
kinase activity and glucose uptake in 3T3-L1 adipocytes
[ 3 3 ] .I n t r i g u i n g ,C A Fa l s od e c r e a s e di n s u l i n - i n d u c e d
GSK3b (Ser9) phosphorylation in a dose-dependent
manner in 3T3-L1 adipocytes. The results of another
study demonstrated that the Ser9 phosphorylation of
GSK3b is increased following insulin treatment, and its
activity is repressed by insulin and lithium chloride (LC)
[33]. Lithium mimics insulin in its stimulation of glu-
cose transport. LC treatment of 3T3-L1 cells inhibited
PPARg expression and adipocyte differentiation [34]. In
addition, a study of Akt-deletion mice showed that Akt
is essential for adipocyte differentiation and for the
induction of PPARg expression [35]. Therefore, our
results indicate that the inhibition of Akt phosphoryla-
tion and activation by CAF blocks hormone-induced
adipocyte differentiation in 3T3-L1 preadipocytes. These
results imply that there is an important association
between PI3K/Akt/GSK3b-mediated signaling and the
transcription factors, PPARg and C/EBPa,i n3 T 3 - L 1
adipocyte differentiation induction. These results iden-
tify one possible mechanism of CAF action, suggesting
that CAF-induced inhibitiono fA k ts u p p r e s s e sa d i p o -
genesis by inhibiting other signaling cascades that
include C/EBPs and PPARg during the process of 3T3-
L1 adipocyte differentiation.
Conclusions
In conclusion, we showed that CAF suppressed adipo-
genesis by down-regulating the expression of PPARg
and C/EBPa as well as by down-regulating the expres-
sion of genes that are relevant to lipid accumulation and
lipid metabolism. CAF also inhibited adipocyte differen-
tiation in 3T3-L1 adipocytes by attenuating the Akt/
GSK3b pathway and by promoting lipolysis of mature
adipocytes. Taken together, our findings provide impor-
tant insights into the mechanisms underlying the anti-
obesity activity of CAF.
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